Suppr超能文献

正常中耳中的Cochlin以及DFNA9和Coch(G88E/G88E)小鼠中耳的异常沉积物。

Cochlin in normal middle ear and abnormal middle ear deposits in DFNA9 and Coch (G88E/G88E) mice.

作者信息

Robertson Nahid G, O'Malley Jennifer T, Ong Cheng Ai, Giersch Anne B S, Shen Jun, Stankovic Konstantina M, Morton Cynthia C

机构信息

Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, NRB 160, Boston, MA, 02115, USA,

出版信息

J Assoc Res Otolaryngol. 2014 Dec;15(6):961-74. doi: 10.1007/s10162-014-0481-9. Epub 2014 Jul 22.

Abstract

DFNA9 sensorineural hearing loss and vestibular disorder, caused by mutations in COCH, has a unique identifying histopathology including prominent acellular deposits in cochlear and vestibular labyrinths. A recent study has shown presence of deposits also in middle ear structures of DFNA9-affected individuals (McCall et al., J Assoc Res Otolaryngol 12:141-149, 2004). To investigate the possible role of cochlin in the middle ear and in relation to aggregate formation, we evaluated middle ear histopathology in our Coch knock-in (Coch (G88E/G88E) ) mouse model, which harbors one of the DFNA9-causative mutations. Our findings reveal accumulation of acellular deposits in the incudomalleal and incudostapedial joints in Coch (G88E/G88E) mice, similar to those found in human DFNA9-affected temporal bones. Aggregates are absent in negative control Coch (+/+) and Coch (-/-) mice. Thickening of the tympanic membrane (TM) found in humans with DFNA9 was not appreciably detected in Coch (G88E/G88E) mice at the evaluated age. We investigated cochlin localization first in the Coch (+/+)mouse and in normal human middle ears, and found prominent and specific cochlin staining in the incudomalleal joint, incudostapedial joint, and the pars tensa of the TM, which are the three sites where abnormal deposits are detected in DFNA9-affected middle ears. Cochlin immunostaining of Coch (G88E/G88E) and DFNA9-affected middle ears showed mutant cochlin localization within areas of aggregates. Cochlin staining was heterogeneous throughout DFNA9 middle ear deposits, which appear as unorganized and overlapping mixtures of both eosinophilic and basophilic substances. Immunostaining for type II collagen colocalized with cochlin in pars tensa of the tympanic membrane. In contrast, immunostaining for type II collagen did not overlap with cochlin in interossicular joints, where type II collagen was localized in the region of the chondrocytes, but not in the thin layer of the articular surface of the ossicles nor in the eosinophilic deposits with specific cochlin staining.

摘要

由COCH基因突变引起的DFNA9感音神经性听力损失和前庭障碍具有独特的组织病理学特征,包括耳蜗和前庭迷路中显著的无细胞沉积物。最近一项研究表明,在受DFNA9影响个体的中耳结构中也存在沉积物(McCall等人,《耳鼻咽喉研究协会杂志》12:141 - 149,2004年)。为了研究耳蜗蛋白在中耳中的可能作用以及与聚集体形成的关系,我们在携带DFNA9致病突变之一的耳蜗敲入(Coch (G88E/G88E) )小鼠模型中评估了中耳组织病理学。我们的研究结果显示,Coch (G88E/G88E) 小鼠的砧镫关节和砧骨镫骨关节中有无细胞沉积物积聚,类似于在受DFNA9影响的人类颞骨中发现的沉积物。阴性对照的Coch (+/+) 和Coch (-/-) 小鼠中没有聚集体。在评估年龄时,Coch (G88E/G88E) 小鼠中未明显检测到DFNA9患者中发现的鼓膜增厚。我们首先在Coch (+/+) 小鼠和正常人类中耳中研究了耳蜗蛋白的定位,发现在砧镫关节、砧骨镫骨关节和鼓膜紧张部有显著且特异性的耳蜗蛋白染色,这些是在受DFNA9影响的中耳中检测到异常沉积物的三个部位。Coch (G88E/G88E) 和受DFNA9影响的中耳的耳蜗蛋白免疫染色显示突变型耳蜗蛋白定位于聚集体区域内。在整个DFNA9中耳沉积物中,耳蜗蛋白染色是异质性的,沉积物表现为嗜酸性和嗜碱性物质的无组织重叠混合物。鼓膜紧张部中II型胶原的免疫染色与耳蜗蛋白共定位。相比之下,在关节间关节中,II型胶原的免疫染色与耳蜗蛋白不重叠,II型胶原定位于软骨细胞区域,但不在听小骨关节表面的薄层中,也不在具有特异性耳蜗蛋白染色的嗜酸性沉积物中。

相似文献

1
Cochlin in normal middle ear and abnormal middle ear deposits in DFNA9 and Coch (G88E/G88E) mice.
J Assoc Res Otolaryngol. 2014 Dec;15(6):961-74. doi: 10.1007/s10162-014-0481-9. Epub 2014 Jul 22.
2
Cochlin immunostaining of inner ear pathologic deposits and proteomic analysis in DFNA9 deafness and vestibular dysfunction.
Hum Mol Genet. 2006 Apr 1;15(7):1071-85. doi: 10.1093/hmg/ddl022. Epub 2006 Feb 15.
4
A targeted Coch missense mutation: a knock-in mouse model for DFNA9 late-onset hearing loss and vestibular dysfunction.
Hum Mol Genet. 2008 Nov 1;17(21):3426-34. doi: 10.1093/hmg/ddn236. Epub 2008 Aug 12.
8
Extralabyrinthine manifestations of DFNA9.
J Assoc Res Otolaryngol. 2011 Apr;12(2):141-9. doi: 10.1007/s10162-010-0245-0. Epub 2010 Nov 4.

引用本文的文献

2
Loss of drives impairments in tendon structure and function.
Matrix Biol Plus. 2025 Feb 15;25:100168. doi: 10.1016/j.mbplus.2025.100168. eCollection 2025 Feb.
3
Loss of drives impairments in tendon structure and function.
bioRxiv. 2024 Nov 14:2024.11.14.623674. doi: 10.1101/2024.11.14.623674.
9
Cochlin Deficiency Protects Aged Mice from Noise-Induced Hearing Loss.
Int J Mol Sci. 2021 Oct 26;22(21):11549. doi: 10.3390/ijms222111549.
10
Cochlin Deficiency Protects Against Noise-Induced Hearing Loss.
Front Mol Neurosci. 2021 May 24;14:670013. doi: 10.3389/fnmol.2021.670013. eCollection 2021.

本文引用的文献

2
Cochlin produced by follicular dendritic cells promotes antibacterial innate immunity.
Immunity. 2013 May 23;38(5):1063-72. doi: 10.1016/j.immuni.2013.01.015. Epub 2013 May 16.
3
Cochlin, intraocular pressure regulation and mechanosensing.
PLoS One. 2012;7(4):e34309. doi: 10.1371/journal.pone.0034309. Epub 2012 Apr 4.
4
Cochlin-tomoprotein (CTP) detection test identifies traumatic perilymphatic fistula due to penetrating middle ear injury.
Acta Otolaryngol. 2011 Sep;131(9):937-44. doi: 10.3109/00016489.2011.575795. Epub 2011 Jun 22.
5
Extralabyrinthine manifestations of DFNA9.
J Assoc Res Otolaryngol. 2011 Apr;12(2):141-9. doi: 10.1007/s10162-010-0245-0. Epub 2010 Nov 4.
6
Role of protein misfolding in DFNA9 hearing loss.
J Biol Chem. 2010 May 14;285(20):14909-14919. doi: 10.1074/jbc.M110.106724. Epub 2010 Mar 12.
7
CTP (Cochlin-tomoprotein) detection in the profuse fluid leakage (gusher) from cochleostomy.
Acta Otolaryngol. 2010 Aug;130(8):881-7. doi: 10.3109/00016480903508910.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验